Company intelligence / Profile preview

MacroArray Diagnostics

Ownership: Private
Development stage: Commercial

Overview

MacroArray Diagnostics has commercialized multiplex immunodiagnostic platforms for allergy and food intolerance testing. Their ALEX/ALEX² systems allow simultaneous measurement of total IgE and specific IgE against hundreds of allergen extracts and molecular allergens. The company’s products are CE-marked, widely adopted in clinical labs, and have expanded into the consumer market with at-home blood test kits under the 7Drops brand.

Therapeutic areas: Immunology
Modalities: DeviceDiagnostic test (immunodiagnostic)
Industry: Protein Biomarker Diagnostics

Drug pipeline

2 assets

ALEX²

Commercial

Indications: IgE-mediated allergies

1 more asset in the full pipeline.

Request access →

Partnerships

ALPCO for US distribution/partnershipsBIT Group for device development/manufacturing partnership

Beyond the preview

Go deeper on MacroArray Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MacroArray Diagnostics.

Explore the full profile